Overview
A pilot, prospective, single-center study for the investigation of the use of Prevena Vacuum-Assisted Closure devices in patients undergoing spine surgery.
Description
The objective of the study is to evaluate the efficacy of the Prevena Plus 125 therapy Unit (KCI USA, Inc.) in preventing surgical site infections and other wound complications in patients undergoing spine surgery compared to conventional wound dressing. Furthermore, the investigators want to illustrate which patients benefit most significantly from Prevena usage as spine surgery sees a range of potential candidates, and not all may experience equivalent recovery from spine surgery with Prevena intervention.
Eligibility
Inclusion Criteria:
- Patients undergoing spine surgery that requires closure by plastic surgeon
- Over 18 years old
- Risk Score Cutoff 80+
- (Control) Matched to a prospective research participant
Exclusion Criteria:
- Risk Score Cutoff <80
- Medical or psychiatric condition that may increase the risk with study participation, may complicate patient compliance, or may interfere with the interpretation of study results and, in the judgement of the Investigator, would make the subject inappropriate for entry into this study
- Subjects who are pregnant at the date of surgery (SOC for surgery)